Genetic testing company 23andMe, once a Silicon Valley darling valued at $6 billion, filed for Chapter 11 bankruptcy protection late Sunday as it prepares for a sale of the business. CEO Anne Wojcicki, who cofounded the company in 2006, has also stepped down after months of failed attempts to take the firm private.
As uncertainty about the company’s future reaches its peak, all eyes are on the trove of deeply personal—and potentially valuable—genetic data that 23andMe holds. Privacy advocates have long warned that the risk of entrusting genetic data to any institution is twofold—the organization could fail to protect it, but it could also hand over customer data to a